Where to Buy Semax: The Nootropic Shop Is Not a Supplier
Summary: Five kinds of seller list this compound and they are in five different businesses, only one of which involves publishing a document about the batch you will receive.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
Where to buy semax comes down to five kinds of seller who are in five different businesses, and only one of them treats publishing a document about your batch as part of the job.
The seller this page keeps measuring the others against is below.
Where readers actually buy it
Ascension Peptides — Semax
Research-grade Semax, tested by two outside labs and shipped from the US. The code below takes half off the vial.
The published certificate for batch 30-05260628 carries a kinetic chromogenic LAL endotoxin test to USP Chapter 85, reporting under 0.20 EU/mL against a 0.5 EU/mL limit, plus a sterility screen. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price.
- Batch certificates from two independent labs
- Free shipping over $250
- Ships same day if ordered before 2pm CST
Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 21, 2026.
What you would be buying, before you decide from whom
This is a GLP-1 site, so the first thing to settle is that Semax has nothing to do with GLP-1 medication. It is not an incretin, it does not act at the GLP-1 receptor, it does not slow gastric emptying, and it carries no weight-management indication in any country. Readers arrive at it because it circulates in the same forums as semaglutide and tirzepatide, usually framed as a focus or drive compound. That is a fact about forums.
What it is: a synthetic heptapeptide, seven amino acids in the order Met-Glu-His-Phe-Pro-Gly-Pro. The first four are the ACTH(4-7) fragment, a short section of adrenocorticotropic hormone, and the Pro-Gly-Pro tail is a stability modification that slows the enzymes which would otherwise clear the chain quickly. PubChem lists it as CID 9811102, formula C37H51N9O10S, molecular weight 813.9 [1]. It was developed in Russia and holds a Russian registration. It has no FDA approval for anything.
The evidence position deserves stating plainly, because it sets a ceiling on how much the sourcing question is worth. The drugs this site normally covers reached the market through large randomised trials with published, checkable results. Semax did not. Its clinical record is mostly Russian-language and mostly unreplicated to Western standards, and the English summaries of it circulating online are routinely quoted at a confidence the underlying work does not carry. A perfect supplier does not change any of that. It changes only whether the powder in the vial is the molecule on the label.
The risk that travels with the compound through every channel
FDA has recorded exactly one substantive concern about Semax, and it is not a vague one. Compounded drugs containing semax (heptapeptide) "may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities", and the agency says it "lacks sufficient information to know whether the drug would cause harm if administered to humans" [2].
That sentence is more useful to a buyer than it looks. Immunogenicity means your immune system reacting to the material itself. The two causes named are aggregation, where peptide molecules clump into larger structures the body reads as foreign, and peptide-related impurities, the truncated and modified sequences that synthesis inevitably leaves behind. Both are consequences of how material was made, purified, filled and stored, which is precisely what the channel you buy through determines.
It also means two separate documents matter rather than one. A purity figure tells you what proportion of the powder is the intended sequence. An endotoxin result tells you about bacterial pyrogen load, which a purity assay cannot detect at all, because endotoxins are cell wall fragments that survive processes which kill the bacteria that produced them [5]. Most of this market publishes the first and not the second.
Where to buy semax: the sellers, and what each one is actually selling
| Seller | What lands on your doorstep | What it will show you on paper | Where it goes wrong | Rough cost |
|---|---|---|---|---|
| Domestic research-peptide supplier | Sealed glass vial of lyophilised powder, labelled for laboratory research only | Usually a batch certificate you can open before paying, occasionally a thorough one | Documentation quality varies enormously between vendors and between lots | $30 to $60 for 10 mg |
| Consumer nootropic retailer | A pre-mixed nasal spray in consumer packaging, presented for human use | Marketing copy, sometimes a purity claim with no document behind it | Human-use presentation without approval, and the format where sterility matters most is the one documented least | $30 to $60 a bottle |
| Overseas marketplace or reshipper | Often the same class of powder, sometimes competently made | A certificate that frequently does not name your lot | Border detention, weeks of uncontrolled transit, no realistic refund path | $10 to $30 plus the cost of a parcel that never arrives |
| The Russian registered product, imported personally | A finished foreign pharmaceutical, in foreign-language packaging | A pharmaceutical label that means nothing to a US regulator | FDA's personal importation policy is enforcement discretion, not a right, and the registration does not transfer [5] | Varies, plus the risk of the whole shipment |
| Compounding pharmacy | Nothing. There is no lawful route for it to prepare this | Not applicable | Any pharmacy offering it has misread its own position | Not applicable |
| Clinic or telehealth provider | Nothing they can lawfully stock as an approved product | Not applicable | A clinic listing it is sourcing from the same grey market you were trying to avoid | Not applicable |
Two rows in that table are unique to this compound rather than generic to peptides, and they are the two that catch people out.
The pharmacy door, and the exact reason it stays shut
Search this question and you will meet confident pages saying Semax is "FDA Category 2", and other pages saying it is banned. Both are wrong, and the true version explains the closed door better than either.
Under section 503A of the FD&C Act, substances nominated for use in compounding get sorted into three categories. Search the current lists, updated May 14, 2026, and Semax is in none of them [3]. Where the name does appear is on a different FDA page, in a table headed as bulk drug substances nominated but withdrawn, which the agency describes as substances previously in category 2 of the interim policies that were withdrawn by the nominators [2].
So the accurate sentence is that Semax was nominated, was placed in category 2 while FDA evaluated it under the interim policies, and the nomination was then withdrawn by the nominator. It sits on no category list today. Current category 2 contains exactly six substances: cesium chloride, domperidone, germanium sesquioxide, ibutamoren mesylate, kisspeptin-10, and quinacrine hydrochloride for intrauterine administration [2]. Semax is not one of them.
That is not a safety ruling in either direction. It means the question was opened and then closed without an answer, which leaves a compounding pharmacy with nothing to work from. No approved product, no category placement, no pathway. The same structural dead end applies to the sibling Russian heptapeptide, and we mapped it channel by channel in why every Selank seller is a research supplier.
It is worth seeing what the opposite looks like. NAD+ genuinely does have a clinic channel, with real infusion appointments at real addresses, which is why the choice there is between a chair, a prescription, or a vial. Semax has no equivalent. Nothing is being withheld from you by a gatekeeper, because there is no gate.
Why the spray retailer looks the most respectable and documents the least
The nasal spray row is where readers lose the thread, because that channel presents better than any other. Consumer packaging. A named concentration. No awkward research-use label. It reads like a product rather than a chemical.
That presentation is doing a great deal of work. A spray marketed for human use has less legal ground under it than a vial explicitly sold for laboratory research, not more. And the format inverts the documentation question. A lyophilised powder is dry, which is why it is sold that way: dry material is stable and does not culture anything. A pre-mixed solution in a multi-use bottle is the format where sterility, preservative content and fill accuracy genuinely matter, and it is the format where those numbers are almost never published.
The vendor we link sells the vial and does not sell a spray. If you specifically want a spray, that is a different market with different sellers, and the honest advice is to ask each of them for a batch document and see what comes back.
Scoring the channel we link, including where it is weaker
We link Ascension Peptides and earn a commission on purchases made through the card above. That is disclosed there and in our disclaimer, and it is the reason to run the comparison strictly rather than gently.
The product is Semax 10 mg, lyophilised, at $59.99 list, or $30.00 with the code PEPTIDEDECK, which is $3.00 per milligram. Stock is domestic, which deletes the border row rather than reducing it, and the listing carries a research-use-only statement.
On documentation it is the strongest thing in this market that we can point at. The published certificate covers batch 30-05260628, report number KVR-2026-E848E0, issued by Kovera Labs [4]. Purity is 99.886% by RP-HPLC against a printed specification of greater than 98%, identity is confirmed by LC-MS, and the sample block carries the formula C37H51N9O10S and CAS number 80714-61-0, matching the public record [1]. Critically for the risk described above, it carries a bacterial endotoxin result by kinetic chromogenic LAL to USP Chapter 85, reported below 0.20 EU/mL against a 0.5 EU/mL acceptance limit, plus a rapid sterility screen returning no growth, and an ICP-MS panel for lead, arsenic, cadmium and mercury.
Where it is weaker: the sterility test is a rapid screen rather than a compendial one, and the document says so itself, noting that full USP Chapter 71 testing may be required for regulatory purposes [4]. The listing copy also gestures at neuroprotective and cognitive properties in research models, which is claim-adjacent language on a compound with no approved indication. And every figure on that certificate describes one batch. If the vial that reaches you carries a different lot number, the document you read was about someone else's powder.
What the price gaps between channels represent
At $30.00 the domestic vial is not the cheapest listing in existence. Overseas listings undercut it, sometimes by a lot, and that saving is entirely real until a parcel is detained, at which point the recovery rate is zero. Quantity tiers of 3%, 5% and 10% apply at 3, 5 and 10 vials against the list price and are a separate mechanism from the code, which is not documented as stacking with them. Free shipping starts at $250. The full arithmetic, including what the assayed overfill does to the per-milligram figure, is on our semax price page.
Questions readers ask
- Where to buy semax if I want it from a pharmacy?
- You cannot. There is no FDA-approved Semax product to dispense, and because the compounding nomination was withdrawn it appears on no current 503A category list, so a compounding pharmacy has no route to prepare it either. A pharmacy offering it is operating outside FDA's interim policies.
- Is buying Semax in the United States legal?
- Selling and buying it as a research chemical is lawful. Selling it for human consumption is not, which is why legitimate suppliers label the vial for laboratory use only. Nothing here is a recommendation to use it.
- Can I import the Russian product instead?
- FDA's personal importation policy is enforcement discretion applied case by case, not a right, and a Russian registration confers nothing in the United States. A detained parcel is not refunded by anyone, and the seller is beyond any practical recourse.
- Does a high purity percentage cover the risk FDA described?
- Only part of it. Purity constrains peptide-related impurities. It says nothing about pyrogen load, which needs a bacterial endotoxin assay of its own, and nothing about sterility. Those are separate lines on a certificate and most sellers do not have them.
- Should I buy the spray or the vial?
- That depends on what documentation you can get, not on which looks more like a product. The spray sellers are a consumer market with generally thinner paperwork, and none of it is approved either. Ask any seller in either format for a lot-specific certificate before paying.
- What single question separates the good sellers from the rest?
- Ask whether they can send the certificate covering the exact lot they will ship you. It tests batch traceability and testing scope at once, and how they answer tells you as much as what they answer.
Where to buy semax has a short answer and a long one. The short answer is a domestic research supplier, because every other channel either cannot lawfully supply it or cannot show you what it is supplying. The long answer is that the channel only sets the ceiling. What decides the purchase is whether a document exists for your batch, and whether that document covers the one risk anybody official has bothered to write down.
References
- PubChem Compound Summary for CID 9811102, Semax, National Library of Medicine
- FDA, Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks, content current as of 04/22/2026
- FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, category lists updated May 14, 2026
- Kovera Labs, Certificate of Analysis, Semax 10 mg, batch 30-05260628, report KVR-2026-E848E0
- FDA, Personal Importation, Import Basics